ALISO VIEJO, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make an investor presentation at the UBS 2007 Global Life Sciences Conference at 4:30 p.m. EDT on Wednesday, September 26, 2007. The conference will be held at the Grand Hyatt in New York City, September 24-27.
A live webcast of the Company's presentation at the conference will be available via a link provided at http://www.clarientinc.com/investor. An archived replay of the presentation will be available shortly after the presentation is concluded for a period of 30 days.
Clarient combines innovative technologies with world class expertise to assess and characterize cancer. Clarient's mission is to provide the services, resources and critical information to improve the quality and reduce the cost of patient care as well as accelerating the drug development process. The Company's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies.
The rise of individualized medicine as the new direction in oncology has created the need for a centralized resource providing leading diagnostic technologies such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory providing the most advanced oncology testing and drug development services available both onsite and over the web. Clarient is a Safeguard Scientifics, Inc. partner company. For more information, visit http://www.clarientinc.com.
Safeguard Scientifics, Inc. (NYSE: SFE), a holding company, builds value in growth-stage technology and life sciences businesses. Safeguard provides growth capital as well as a range of strategic, operating and management resources to our partner companies. Safeguard participates in growth buyout financings, including corporate spin-outs and management buyouts, expansion financings, industry consolidations and early-stage financings. http://www.safeguard.com
Matt Clawson John Baldissera
Allen & Caron, Inc. BPC Financial Marketing
(949) 474-4300 (800) 368-1217
|SOURCE Clarient, Inc.|
Copyright©2007 PR Newswire.
All rights reserved